Saumya Das

Title: Saumya Das: Innovator in Cardiac Treatment

Introduction

Saumya Das is a prominent inventor based in Lexington, MA (US), known for her significant contributions to the field of cardiac treatment. With a total of 4 patents, she has focused her research on innovative methods to address heart conditions, both acquired and genetic.

Latest Patents

One of her latest patents involves the inhibition of SGK1 in the treatment of heart conditions. This invention relates to treating various cardiovascular diseases, including Long QT syndrome and dilated cardiomyopathy, through the selective inhibition of SGK1. The method includes administering a therapeutically effective amount of an SGK1 inhibitor to the subject. Additionally, she has developed a patent that features methods to predict the response to cardiac therapy in patients suffering from heart failure. This invention emphasizes the measurement of biomarkers that aid in predicting treatment responses and includes methods for cardiac resynchronization therapy and miRNA-based therapeutics.

Career Highlights

Saumya Das is affiliated with Beth Israel Deaconess Medical Center, Inc., where she continues her groundbreaking research. Her work has garnered attention for its potential to revolutionize the treatment of heart diseases.

Collaborations

Some of her notable coworkers include Anthony Rosenzweig and Alan C Rigby, who contribute to her research endeavors.

Conclusion

Saumya Das is a trailblazer in the field of cardiac treatment, with her innovative patents paving the way for new therapeutic approaches. Her work exemplifies the impact of research on improving patient outcomes in cardiovascular health.